S. Szmit

Insufficient control of classical atherosclerotic risk factors in patients with non-metastatic breast cancer referred for anticancer therapy

Women with non-metastatic breast cancer frequently present with suboptimal control of cardiovascular risk factors at the time of qualification for anticancer therapy, and cardio-oncology care should focus on optimal blood pressure management and aggressive modification of metabolic risk factors, including obesity and dyslipidemia.